Patent · US Active

Method and composition for targeted delivery of therapeutic agents

US11185501B2 · kind B2 · utility

0Cited by
3References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 11, 2019
Grant dateNov 30, 2021
Priority date
Expiry dateOct 11, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/32
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Functionalized single walled or multi-walled carbon nanotubes (f-CNTs) can be delivered into mammals to targeted organs, such as the kidney and the liver. These f-CNTs may be non-covalently linked or covalently linked to therapeutic agents. In particular, the application delivers carbon nanotube-therapeutic agent conjugates to a target organ, thereby preventing or reducing damages to the organ caused by other agents or procedure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.